Continued Increase in Incidence of Kidney Cancer in Iran and its 31 Provinces

IF 0.4 Q4 ONCOLOGY International Journal of Cancer Management Pub Date : 2024-07-14 DOI:10.5812/ijcm-137009

M. Nowroozi, Ehsan Mosa Farkhani, K. Hushmandi, E. Amini, Seyed Ali Momeni, Seyed Hassan Inanloo, L. Sharifi, S. Bokaie

{"title":"Continued Increase in Incidence of Kidney Cancer in Iran and its 31 Provinces","authors":"M. Nowroozi, Ehsan Mosa Farkhani, K. Hushmandi, E. Amini, Seyed Ali Momeni, Seyed Hassan Inanloo, L. Sharifi, S. Bokaie","doi":"10.5812/ijcm-137009","DOIUrl":null,"url":null,"abstract":"Background: Kidney cancer in adults includes malignant tumors originating from the parenchyma and pelvis and is the most lethal urogenital cancer. Available data in Iran indicate that the incidence and pattern of this cancer are changing. Objectives: Our study aimed to present an updated incidence rate of kidney cancer in Iran and its 31 provinces and their trends, and climate zones distribution of the disease. Methods: In this study, the age standard incidence rate (ASIR) of kidney cancer based on provinces, age groups, and gender has been calculated using the available data in the national cancer registration system of the Ministry of Health from 2003 to 2016. Results: Overall ASIR of kidney cancer was 1.28 per 100,000 from 2003 to 2016. ASIR of this cancer in men has increased from 0.96 in 2003 to 3.66 in 2016 and similarly, reached from 0.61 in 2003 to 2.24 in 2016 in Iran. Fars, Yazd, Tehran and Isfahan provinces had the highest ASIR in Iran. Hot climate zones are associated with a higher incidence of kidney cancer while moderate climate is linked to lower incidence rates in Iran. Conclusions: Although the incidence rate of kidney cancer in Iran and its provinces is low, the increasing trend is concerning particularly among men. Therefore, it is crucial to develop cost-effective screening tests and implement control and prevention programs in the high-incidence provinces.","PeriodicalId":44764,"journal":{"name":"International Journal of Cancer Management","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/ijcm-137009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Kidney cancer in adults includes malignant tumors originating from the parenchyma and pelvis and is the most lethal urogenital cancer. Available data in Iran indicate that the incidence and pattern of this cancer are changing. Objectives: Our study aimed to present an updated incidence rate of kidney cancer in Iran and its 31 provinces and their trends, and climate zones distribution of the disease. Methods: In this study, the age standard incidence rate (ASIR) of kidney cancer based on provinces, age groups, and gender has been calculated using the available data in the national cancer registration system of the Ministry of Health from 2003 to 2016. Results: Overall ASIR of kidney cancer was 1.28 per 100,000 from 2003 to 2016. ASIR of this cancer in men has increased from 0.96 in 2003 to 3.66 in 2016 and similarly, reached from 0.61 in 2003 to 2.24 in 2016 in Iran. Fars, Yazd, Tehran and Isfahan provinces had the highest ASIR in Iran. Hot climate zones are associated with a higher incidence of kidney cancer while moderate climate is linked to lower incidence rates in Iran. Conclusions: Although the incidence rate of kidney cancer in Iran and its provinces is low, the increasing trend is concerning particularly among men. Therefore, it is crucial to develop cost-effective screening tests and implement control and prevention programs in the high-incidence provinces.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

伊朗及其 31 个省的肾癌发病率持续上升

背景：成人肾癌包括源自肾实质和肾盂的恶性肿瘤，是致死率最高的泌尿生殖系统癌症。伊朗的现有数据表明，这种癌症的发病率和发病模式正在发生变化。研究目的我们的研究旨在介绍伊朗及其 31 个省肾癌的最新发病率及其趋势，以及该疾病的气候区分布情况。研究方法在本研究中，我们使用卫生部全国癌症登记系统中 2003 年至 2016 年的可用数据，计算了各省、年龄组和性别的肾癌年龄标准发病率（ASIR）。结果显示从 2003 年到 2016 年，肾癌的总体 ASIR 为每 10 万人 1.28 例。伊朗男性肾癌的 ASIR 从 2003 年的 0.96 增至 2016 年的 3.66，同样，也从 2003 年的 0.61 增至 2016 年的 2.24。伊朗法尔斯、亚兹德、德黑兰和伊斯法罕省的 ASIR 最高。在伊朗，气候炎热地区的肾癌发病率较高，而气候温和地区的发病率较低。结论：虽然伊朗及其各省的肾癌发病率较低，但其增长趋势令人担忧，尤其是男性。因此，在高发省份开发具有成本效益的筛查测试并实施控制和预防计划至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

International Journal of Cancer Management ONCOLOGY-

CiteScore

1.10

自引率

0.00%

发文量

期刊介绍： International Journal of Cancer Management (IJCM) publishes peer-reviewed original studies and reviews on cancer etiology, epidemiology and risk factors, novel approach to cancer management including prevention, diagnosis, surgery, radiotherapy, medical oncology, and issues regarding cancer survivorship and palliative care. The scope spans the spectrum of cancer research from the laboratory to the clinic, with special emphasis on translational cancer research that bridge the laboratory and clinic. We also consider original case reports that expand clinical cancer knowledge and convey important best practice messages.